Stiripentol in Dravet syndrome: Results of a retrospective U.S. study

Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome

(2012) A. Brunklaus et al.   BRAIN

Successful use of fenfluramine as an add-on treatment for Dravet syndrome

(2012) Berten Ceulemans et al.   EPILEPSIA

Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus

(2012) Denise K. Grosenbaugh et al.   NEUROPHARMACOLOGY

Cognitive development in children with Dravet syndrome

(2011) Francesca Ragona   EPILEPSIA

Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome

(2011) Masako Sakauchi et al.   EPILEPSIA

Nonpharmacologic treatments of Dravet syndrome: Focus on the ketogenic diet

(2011) Roberto Horacio Caraballo   EPILEPSIA

The pharmacologic treatment of Dravet syndrome

(2011) Catherine Chiron et al.   EPILEPSIA

Dravet syndrome: The long-term outcome

(2011) Pierre Genton et al.   EPILEPSIA

Dravet syndrome and parent associations: The IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief

(2011) Joan V. Skluzacek et al.   EPILEPSIA

Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: A prospective pilot study

(2011) Rima Nabbout et al.   EPILEPSIA

Interactions between modulators of the GABAA receptor: Stiripentol and benzodiazepines

(2011) Janet L. Fisher   EUROPEAN JOURNAL OF PHARMACOLOGY

A long-term follow-up study of Dravet syndrome up to adulthood

(2009) Mari Akiyama et al.   EPILEPSIA

Stiripentol open study in Japanese patients with Dravet syndrome

(2009) Yushi Inoue et al.   EPILEPSIA

Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome) – A nationwide questionnaire survey in Japan

(2008) Takuya Tanabe et al.   BRAIN & DEVELOPMENT

The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator

(2008) Janet L. Fisher   NEUROPHARMACOLOGY